GlassScriptPhysician profile
Nidhi S Modi
NPI 1386931129
$1,584.32
in general payments reported to CMS, 2019-2025
17 companies · $445 in 2025
The $445 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.93 · 2020: $55.68 · 2021: $204 · 2022: $222 · 2023: $263 · 2024: $340 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $922.59 | 2021-2025 | |
| Medtronic, INC. | $202.67 | 2024-2025 | Percept PC Brainsense |
| Novartis Pharmaceuticals Corporation | $93.15 | 2020-2023 | |
| Biogen, INC. | $77.33 | 2019-2025 | Tysabri |
| Argenx US, INC. | $58.34 | 2022-2024 | Vyvgart, Vyvgart Hytrulo |
| Emd Serono, INC. | $39.47 | 2021-2025 | |
| Allergan, INC. | $28.47 | 2021 | |
| Ucb, INC. | $20.45 | 2024 | Briviact |
| Eisai INC. | $19.00 | 2025 | |
| Alexion Pharmaceuticals, INC. | $18.80 | 2024 | Ultomiris |
| Lundbeck LLC | $18.76 | 2025 | Vyepti |
| Horizon Therapeutics Plc | $16.42 | 2022 | |
| Pfizer INC. | $15.78 | 2023 | |
| Strongbridge US INC. | $15.29 | 2019 | |
| Scilex Pharmaceuticals INC. | $13.63 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $12.09 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidhi Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.